Thursday - September 3, 2026
HudsonAlpha Welcomes New Vice President for Translational Health Science, Jennifer Lovejoy
September 02, 2026
HUNTSVILLE, Alabama, Sept. 2 -- The HudsonAlpha Institute for Biotechnology issued the following news:

* * *

HudsonAlpha Welcomes New Vice President for Translational Health Science, Jennifer Lovejoy

Lovejoy will lead HOPE AD and related multi omic, longitudinal, and intervention-based programs focused on chronic disease prevention and precision health.

-

The HudsonAlpha Institute for Biotechnology recently welcomed Jennifer Lovejo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products